ALNY   $273.89  -0.93% Market Closed

Alnylam Pharmaceuticals Inc

EMA (20): 2024-09-11 the price crossed up the moving average line and demonstrates a strong upside trend.

EMA (50): 2024-09-09 the price crossed up the moving average line and formed a short-term upside trend.

EMA (100): 2024-06-20 the price crossed up the moving average line and demonstrates an upside trend.

RSI: RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the positive territory it's higher than the signal line and grows. These factors mean that positive mood prevails. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in overbought territory and it heading north. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: main and signal line crossing.

Trend Type turning up
Power strong
Trend Pattern
EMA (20) Signals bullish reversal
EMA (20) Yield 6.20%
EMA (20) date of signal Sept. 11, 2024, 3 a.m.
EMA (50) Signals bullish reversal
EMA (50) Yield 9.91%
EMA (50) date of signal Sept. 9, 2024, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 76.68%
EMA (100) date of signal June 20, 2024, 3 a.m.
RSI Signals bullish recovery
RSI (14) Yield 0.0
RSI (14) date of signal Sept. 19, 2024, 3 a.m.
MACD Signals bullish
MACD Yield 6.28%
MACD date of signal Sept. 12, 2024, 3 a.m.
Stochastic Signals bullish weakening
Stochastic Yield 1.85%
Stochastic date of signal Sept. 18, 2024, 3 a.m.
Updated Sept. 19, 2024, 11 p.m.